Hertz Family Foundation Announces $385,000 Gift to Fund UCLA Practice and Research Advancing Technology and Treatment for Congenital Heart Disease

Said Judah Hertz, founder and CEO of the Hertz Investment Group: “Researchers at ACHDC are now expanding their mission to develop prosthetic materials and mechanical devices that will further prolong and enrich the lives of the individuals they have saved."

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
ACHDC was the first medical center in the country specifically established to treat adolescents and adults with congenital heart disease and is today among the largest of its kind in the world.

Santa Monica, CA (PRWEB) April 20, 2011

The Hertz Family Foundation of Santa Monica, California has announced a major medical research and technology grant to the University of California at Los Angeles. The $385,000 grant will be paid over two years and will be administered by the Ahmanson/UCLA Adult Congenital Heart Disease Center(ACHDC), located on the university’s Westwood Campus in Los Angeles. ACHDC was the first medical center in the country specifically established to treat adolescents and adults with congenital heart disease and is today among the largest of its kind in the world.

Said Judah Hertz, founder and CEO of the Hertz Investment Group: “Because of the Center’s pioneering success, thousands of children with congenital heart disease are now surviving into adulthood. Researchers at ACHDC are now expanding their mission to develop prosthetic materials and mechanical devices that will further prolong and enrich the lives of the individuals they have saved. We are elated this important technology project will be headed by Drs. Jamil Aboulhosn and Hillel Laks, two of the world’s leading authorities on congenital heart disease in adults.”

Dr. Hillel Laks is a world renowned leader in the surgical treatment of congenital heart disease and is the former Chief of Cardiothoracic Surgery at UCLA. Dr. Aboulhosn and his UCLA colleague, Dr. Daniel Levi, headed up the first team at UCLA to implant an artificial heart valve in a human being using a catheter.

Said Dr. Aboulhosn, who is also ACHDC co-director: “Judah Hertz has been a steady friend of ACHDC over more than a decade, and we are delighted that he and his generous family have now chosen to provide the initial funding we need to advance technology and techniques that will further sustain the lives of those born with defective hearts.”

The Hertz family has led the ACHDC’s annual fundraiser ever since its inception in 1999, raising more than $2 million for research and expansion of the Center. In addition to its emphasis on the highest quality of patient care, the Ahmanson/UCLA Adult Congenital Heart Disease Center is now also a major training and research facility for medical and pediatric house officers, medical and pediatric cardiologists, and visiting cardiologists from the United States and abroad.

# # #


Contact